Tradewinds LLC’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
BC
Tradewinds LLC's XBI Position: Q2 2025 in Review
Tradewinds LLC sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2025, closing a stake of 3,146 shares — an estimated $255K sold.
Tradewinds LLC first reported a position in XBI in Q4 2024 and held it in 2 quarters. The position peaked at $509K in Q4 2024. 625 funds tracked by Wall St. Rank hold XBI as of Q2 2025.
- Tradewinds LLC reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2025 after selling out during the quarter.
- Tradewinds LLC sold 3,146 State Street SPDR S&P Biotech ETF shares in Q2 2025, an estimated $255K.
- Tradewinds LLC first reported a position in State Street SPDR S&P Biotech ETF in Q4 2024 and held it in 2 quarters.
- Tradewinds LLC's State Street SPDR S&P Biotech ETF position peaked at $509K in Q4 2024.
- 625 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2025.
Based on Tradewinds LLC's 13F filing for Q2 2025, filed 6 Aug 2025.